[go: up one dir, main page]

WO2003023027A3 - Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy - Google Patents

Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy Download PDF

Info

Publication number
WO2003023027A3
WO2003023027A3 PCT/DE2002/003371 DE0203371W WO03023027A3 WO 2003023027 A3 WO2003023027 A3 WO 2003023027A3 DE 0203371 W DE0203371 W DE 0203371W WO 03023027 A3 WO03023027 A3 WO 03023027A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumoral
therapy
agent
detection
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2002/003371
Other languages
German (de)
French (fr)
Other versions
WO2003023027A2 (en
Inventor
Villiers-Zur Hausen Ethel-M De
Hausen Harald Zur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Priority to AU2002340728A priority Critical patent/AU2002340728A1/en
Publication of WO2003023027A2 publication Critical patent/WO2003023027A2/en
Publication of WO2003023027A3 publication Critical patent/WO2003023027A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed are DNA sequences comprising the genome of a tumor-associated TT virus or fragments thereof. The invention also relates to proteins coded by said DNA sequences, antibodies directed at said proteins, ribozomes directed at MRNAs, antisense RNAs and the use thereof in diagnosis and therapy. The invention also relates to kits containing suitable reagents for diagnosis, e.g. kits containing antibodies.
PCT/DE2002/003371 2001-09-10 2002-09-10 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy Ceased WO2003023027A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002340728A AU2002340728A1 (en) 2001-09-10 2002-09-10 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10144346.3 2001-09-10
DE2001144346 DE10144346A1 (en) 2001-09-10 2001-09-10 TT virus sequences in human tumor tissues, means for their detection and tumor therapy

Publications (2)

Publication Number Publication Date
WO2003023027A2 WO2003023027A2 (en) 2003-03-20
WO2003023027A3 true WO2003023027A3 (en) 2003-11-27

Family

ID=7698369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2002/003371 Ceased WO2003023027A2 (en) 2001-09-10 2002-09-10 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy

Country Status (3)

Country Link
AU (1) AU2002340728A1 (en)
DE (1) DE10144346A1 (en)
WO (1) WO2003023027A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2422536C1 (en) * 2009-10-19 2011-06-27 Российская Федерация, от имени которой выступает Федеральное Агентство по науке и инновациям SET OF SYNTHETIC OLIGONUCLEOTIDES FOR DNA IDENTIFICATION IN BLOOD AND OTHER BIOMATERIALS OF INFECTIOUS AGENT OF LATENT VIRAL INFECTION VIRUS Torque teno virus OF Circoviridae FAMILY BY POLYMERASE CHAIN REACTION
DK2399928T3 (en) * 2010-06-23 2018-01-29 Deutsches Krebsforsch Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in the diagnosis, prevention and treatment of cancer and autoimmunity
US20110318363A1 (en) 2010-06-23 2011-12-29 Deutsches Krebsforschungszentrum Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
DK2585477T3 (en) * 2010-06-23 2018-09-03 Deutsches Krebsforsch RELEASED TT VIRUS MOLECULES FOR USE FOR DIAGNOSTICATION, PREVENTION AND TREATMENT OF CANCER AND AUTO-IMMUNITY
US9676828B2 (en) 2010-06-23 2017-06-13 Deutsches Krebsforschungszentrum Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058638A2 (en) * 1998-05-13 1999-11-18 Innogenetics N.V. Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
WO2000028039A2 (en) * 1998-11-10 2000-05-18 Diasorin International Inc. Identification of senv genotypes
WO2001042299A2 (en) * 1999-12-10 2001-06-14 Roche Diagnostics Gmbh Hepatitis virus sentinel virus i (svi)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058638A2 (en) * 1998-05-13 1999-11-18 Innogenetics N.V. Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
WO2000028039A2 (en) * 1998-11-10 2000-05-18 Diasorin International Inc. Identification of senv genotypes
WO2001042299A2 (en) * 1999-12-10 2001-06-14 Roche Diagnostics Gmbh Hepatitis virus sentinel virus i (svi)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 5 October 1999 (1999-10-05), XP002246328, accession no. EBI Database accession no. AB028301 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; May 2000 (2000-05-01), SOUVIGNET C. AND ZARSKI J.P.: "Gene therapy approaches in chronic viral hepatitis", XP002246329, accession no. EPO Database accession no. NLM10967709 *
DE VILLIERS E.-M. ET AL.: "Heterogeneity of TT virus related sequences isolated from human tumour biopsy specimens", JOURNAL OF MOLECULAR MEDICINE, vol. 80, no. 1, January 2002 (2002-01-01), pages 44 - 50, XP002246327 *
ERKER J C ET AL: "Analyses of TT virus full-length sequences", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 80, 1999, pages 1743 - 1750, XP002168924, ISSN: 0022-1317 *

Also Published As

Publication number Publication date
AU2002340728A1 (en) 2003-03-24
DE10144346A1 (en) 2003-04-03
WO2003023027A2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
WO2007024708A3 (en) Rna containing modified nucleosides and methods of use thereof
WO2006089001A3 (en) Lentiviral vectors and their use
WO2003016475A3 (en) Nucleic acid and amino acid sequences involved in pain
WO2002092836A3 (en) Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
WO2005100998A3 (en) Membrane markers for use in cancer diagnosis and therapy
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
WO1999047669A3 (en) Human nucleic acid sequences from tissue of breast tumors
WO2003016464A3 (en) Cancer specific oligosaccharide sequences and use thereof
WO1999053040A3 (en) Human nucleic acid sequences from ovarian tumour tissue
WO2005016132A3 (en) Diagnostics for sars virus
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2004076614A3 (en) Human nucleic acid sequences obtained from prostatic carcinomas
WO2003023027A3 (en) Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
WO2004051269A3 (en) Ciz1 replication protein
WO1999058639A3 (en) Structural proteins of fish pancreatic disease virus and uses thereof
WO2005049793A3 (en) Methods and compositions for combinatorial approaches to cancer gene therapy
WO1999046375A3 (en) Human nucleic acid sequences from prostate tissue
WO2004059002A3 (en) Method for determining the homeostasis of hairy skin
WO2001032693A3 (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
WO2002093519A3 (en) Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
WO2004015390A3 (en) Lung cancer target proteins and use thereof
WO2000050451A3 (en) Protein (tp) that is involved in the development of the nervous system
WO2005001096A8 (en) Vaccines against sars
WO1998042847A3 (en) Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination
EP1383875A4 (en) Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DK DZ EC EE ES FI GB GD GE GH GM HR ID IL IN IS JP KE KG KP KR KZ LC LK LS LT LU LV MA MD MG MK MN MW MZ NO NZ OM PH PL PT RO RU SD SE SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP